Free Trial
NASDAQ:VXRT

Vaxart (VXRT) Stock Price, News & Analysis

Vaxart logo
$0.37 +0.02 (+4.88%)
As of 08/27/2025 03:59 PM Eastern

About Vaxart Stock (NASDAQ:VXRT)

Key Stats

Today's Range
$0.34
$0.38
50-Day Range
$0.30
$0.61
52-Week Range
$0.26
$1.07
Volume
462,913 shs
Average Volume
2.94 million shs
Market Capitalization
$85.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00
Consensus Rating
Buy

Company Overview

Vaxart Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
42nd Percentile Overall Score

VXRT MarketRank™: 

Vaxart scored higher than 42% of companies evaluated by MarketBeat, and ranked 681st out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Vaxart has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Vaxart has received no research coverage in the past 90 days.

  • Read more about Vaxart's stock forecast and price target.
  • Earnings Growth

    Earnings for Vaxart are expected to grow in the coming year, from ($0.39) to ($0.38) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vaxart is -1.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vaxart is -1.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Vaxart has a P/B Ratio of 1.44. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Vaxart's valuation and earnings.
  • Percentage of Shares Shorted

    3.62% of the float of Vaxart has been sold short.
  • Short Interest Ratio / Days to Cover

    Vaxart has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vaxart has recently decreased by 8.25%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Vaxart does not currently pay a dividend.

  • Dividend Growth

    Vaxart does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.62% of the float of Vaxart has been sold short.
  • Short Interest Ratio / Days to Cover

    Vaxart has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vaxart has recently decreased by 8.25%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Vaxart this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    Only 5 people have added Vaxart to their MarketBeat watchlist in the last 30 days. This is a decrease of -44% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Vaxart insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.80% of the stock of Vaxart is held by insiders.

  • Percentage Held by Institutions

    Only 18.05% of the stock of Vaxart is held by institutions.

  • Read more about Vaxart's insider trading history.
Receive VXRT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vaxart and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VXRT Stock News Headlines

Vaxart Discusses Reverse Stock Split Proposal
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
Vaxart, Inc. (VXRT) Q2 2025 Earnings Call Transcript
See More Headlines

VXRT Stock Analysis - Frequently Asked Questions

Vaxart's stock was trading at $0.6621 on January 1st, 2025. Since then, VXRT stock has decreased by 43.5% and is now trading at $0.3740.

Vaxart, Inc. (NASDAQ:VXRT) announced its quarterly earnings data on Tuesday, May, 13th. The biotechnology company reported ($0.07) earnings per share for the quarter, meeting the consensus estimate of ($0.07). The biotechnology company earned $20.88 million during the quarter, compared to the consensus estimate of $2.85 million. Vaxart had a negative trailing twelve-month return on equity of 91.89% and a negative net margin of 122.63%.
Read the conference call transcript
.

Vaxart shares reverse split on Wednesday, February 14th 2018.The 1-11 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 13th 2018. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split.

Vaxart's top institutional shareholders include Geode Capital Management LLC (1.02%), Marshall Wace LLP (0.77%), Raymond James Financial Inc. (0.10%) and Invesco Ltd. (0.05%).
View institutional ownership trends
.

Shares of VXRT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vaxart investors own include Plug Power (PLUG), Workhorse Group (WKHS), FuelCell Energy (FCEL), Fortress Biotech (FBIO), Assertio (ASRT), Ovid Therapeutics (OVID) and KALA BIO (KALA).

Company Calendar

Last Earnings
5/13/2025
Today
8/28/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VXRT
Previous Symbol
NASDAQ:NABI
CIK
72444
Employees
120
Year Founded
2004

Price Target and Rating

High Price Target
$2.00
Low Price Target
$2.00
Potential Upside/Downside
+434.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.25)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$66.95 million
Net Margins
-122.63%
Pretax Margin
-121.98%
Return on Equity
-91.89%
Return on Assets
-38.40%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.64
Quick Ratio
0.64

Sales & Book Value

Annual Sales
$47.40 million
Price / Sales
1.81
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.26 per share
Price / Book
1.44

Miscellaneous

Outstanding Shares
228,922,000
Free Float
222,374,000
Market Cap
$85.62 million
Optionable
Optionable
Beta
1.12

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:VXRT) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners